An article titled “SSRI antidepressants: altered psychomotor development following exposure in utero?” that appeared in the February, 2013 edition of Prescrire International examines additional risks of prenatal exposure to selective serotonin reuptake inhibitor drugs (SSRIs). To be
Justinian Lane
Justinian Lane is a legal publisher specializing in asbestos and mesothelioma claims, operated as a division of Justinian C. Lane, Esq. – PLLC. The organization provides detailed information on asbestos litigation, related diseases, and compensation claims, including guidance on filing asbestos claims and understanding asbestos trusts. Their content covers various sources of asbestos exposure, symptoms, treatments, and legal history. The publisher also addresses related legal areas such as workers' compensation, veterans disability claims, and maritime claims. Justinian Lane maintains a database of asbestos trusts and offers resources for affected individuals seeking legal assistance and compensation.
Latest from Justinian Lane - Page 4
2013 – Researchers show that SSRIs (not maternal depression) cause poor neonatal outcomes
By Jared Fink
Last summer, a team of researchers from University of British Columbia (Vancouver) led by G.E. Hanley published a study titled “Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.” in Early Human…
Prozac, Pazil, Zoloft, Celexa linked to Persistent Pulmonary Hypertension of the Newborn (PPHN)
By Jared Fink
Titled “Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.”, this article appearing in the October, 2012 edition of CNS Drugs by M. Galbally et al., identifies persistent pulmonary hypertension of the…
2006 – Persistent Pulmonary Hypertension Linked to SSRIs in Pregnancy
By Jared Fink
A team of researchers from Sydney, Australia (led by M.P. Austin) published an article in a December, 2006 edition of Psychological Medicine titled “To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects.…
More research links poor development with SSRI exposure
By Jared Fink
An article in Early Human Development (February, 2013) by M.V. Smith et al. titled “Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.”, from The Yale School of Medicine delves further into…
Huge birth defect increase with Depacon / Depakene / Depakote in pregnancy
By Jared Fink
Today, I came across an article from the February, 2012 edition of The Australian and New Zealand Journal of Obstetrics and Gynecology published by F.J. Vajda and a team of researchers at University of Melbourne (Australia). In their piece, titled…
JAMA: Autism risk 500% increased with Depakote, Depakene, and Depacon in utero
By Jared Fink
In the April, 2013 edition of JAMA, an article titled “Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.” from a Danish team led by J. Christensen evaluated the risks of prenatal exposure to the…
Birth defects at significantly higher rate with Depacon, Depakene
By Jared Fink
Titled “Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.”, an article by J. Morrow and a team from Belfast (UK) published in the February, 2006 edition of Journal of…
2014 – Increased risk for birth defects seen with Depakote exposure
By Jared Fink
In July, 2014, a team of Norwegian researchers led by K.O. Nakken published an article in Tidsskr Nor Laegeforen titled “Antiepileptic drugs and congenital malformations”, evaluating the consequences of prenatal exposure to epilepsy drugs containing sodium valproate, such…
2008 – Epilepsy drugs with valproate linked to higher risk of birth defects, low IQ
By Jared Fink
From Stockholm, Sweden, a 2008 piece titled “Teratogenic effects of antiepileptic drugs.” and appearing in the medical journal, Seizure, by T. Tomson et al. yet again demonstrates the postnatal risks of prenatal exposure to epilepsy drugs containing sodium…